- Filed
- May 9, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 89.51M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 132.35M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $635K |
| Capex restated | Q1 2024 · Mar 31, 2023 | $1.49M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | $1.53M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $924K |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $32.89M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $35.6M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $58.05M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $53.67M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $17.41M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $20.31M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $28.34M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $31.49M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $70.92M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $69.85M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $110.96M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $108.97M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.01 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.04 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.01 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.04 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $20.22M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $14.47M |
| Net Income | Q1 2024 · Mar 31, 2024 | −$539K |
| Net Income | Q1 2024 · Mar 31, 2023 | $2.95M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$1.11M |
| Operating Income | Q1 2024 · Mar 31, 2023 | $4.68M |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $31.88M |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $27.67M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $16.17M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $13.3M |
| Revenue | Q1 2024 · Mar 31, 2024 | $48.05M |
| Revenue | Q1 2024 · Mar 31, 2023 | $40.97M |